These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19383979)

  • 1. A multicenter, open-label, 24-week follow-up study for efficacy on cognitive function of donepezil in Binswanger-type subcortical vascular dementia.
    Kwon JC; Kim EG; Kim JW; Kwon OD; Yoo BG; Yi HA; Choi NC; Ahn SY; Lee BH; Kang MJ; Choi DS;
    Am J Alzheimers Dis Other Demen; 2009; 24(4):293-301. PubMed ID: 19383979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size.
    Román GC; Salloway S; Black SE; Royall DR; Decarli C; Weiner MW; Moline M; Kumar D; Schindler R; Posner H
    Stroke; 2010 Jun; 41(6):1213-21. PubMed ID: 20395618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities.
    Rosenblatt A; Gao J; Mackell J; Richardson S
    Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments.
    Greene YM; Tariot PN; Wishart H; Cox C; Holt CJ; Schwid S; Noviasky J
    J Clin Psychopharmacol; 2000 Jun; 20(3):350-6. PubMed ID: 10831023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
    Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
    Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
    Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
    Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.
    Tariot P; Salloway S; Yardley J; Mackell J; Moline M
    BMC Res Notes; 2012 Jun; 5():283. PubMed ID: 22681723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
    Salloway S; Ferris S; Kluger A; Goldman R; Griesing T; Kumar D; Richardson S;
    Neurology; 2004 Aug; 63(4):651-7. PubMed ID: 15326237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil in vascular dementia: a randomized, placebo-controlled study.
    Wilkinson D; Doody R; Helme R; Taubman K; Mintzer J; Kertesz A; Pratt RD;
    Neurology; 2003 Aug; 61(4):479-86. PubMed ID: 12939421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S; Feldman H; Hecker J; Vellas B; Emir B; Subbiah P;
    Curr Med Res Opin; 2002; 18(6):347-54. PubMed ID: 12442882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of low-dose donepezil in schizophrenia.
    Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA
    Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.
    Ikeda M; Mori E; Kosaka K; Iseki E; Hashimoto M; Matsukawa N; Matsuo K; Nakagawa M;
    Dement Geriatr Cogn Disord; 2013; 36(3-4):229-41. PubMed ID: 23949147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.